Status:
ENROLLING_BY_INVITATION
Combined Antibody Screening for Celiac and Diabetes Evaluation
Lead Sponsor:
Pacific Northwest Research Institute
Collaborating Sponsors:
University of Exeter
Conditions:
Type 1 Diabetes
Celiac Disease
Eligibility:
All Genders
1-7 years
Brief Summary
The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an observational study whose primary goal is to show that population-based screening for advanced prediction of ty...
Eligibility Criteria
Inclusion
- Child must be between 0 to 8 months in age or between 4 to 7 years in age. Child must be born in the state of Washington.
Exclusion
- \-
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
64410 Patients enrolled
Trial Details
Trial ID
NCT04677699
Start Date
December 1 2020
End Date
June 1 2026
Last Update
December 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacific Northwest Research Institute
Seattle, Washington, United States, 98122